EMD Serono, ACP Work Jointly to Make MS Clinical Trials More Patient-focused
News
The Accelerated Cure Project (ACP) for Multiple Sclerosis and EMD Serono— a unit of Merck KGaA — will jointly incorporate the perspectives of U.S. and Canadian multiple sclerosis (MS) patients into the ... Read more